FDA approves first over-the-counter birth control pill in the U.S.
The oral contraceptive Opill isn’t expected to be on store shelves until early next year.
Related Articles
Endocrine Society, Other Medical Organizations Issue Joint Statement on United States v. Skrmetti Decision – Endocrine News
As experts dedicated to providing patients with compassionate, evidence-based care every day, we are disappointed in the United States v. Skrmetti decision, which increases the…
First Impressions: Talking with First-Time ENDO 2024 Attendees – Endocrine News
Once again, Endocrine News chats with a group of members whose trip to Boston made quite an impression on them when they experienced their very…
Endocrine Society Makes Strides Over Past 12 Months – Endocrine News
As I come to the end of my term at ENDO 2025 next month in San Francisco, Calif., I can look back with great pride…
Bright Minds. Bold City. – Endocrine News
Endocrinology’s brightest minds will gather once again in San Francisco from July 12–15 for ENDO 2025. Showcasing groundbreaking research, cutting-edge clinical advances, and abstract discussions…
Pharma Fridays – June 13, 2025 – Endocrine News
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * MiniMed to be Metronic’s New Diabetes Company On June 12, Medtronic…
New Study Questions BMI Accuracy in Childhood Obesity Screening – Endocrine News
A new study from the Avon Longitudinal Study of Parents and Children (ALSPAC) is challenging long-held assumptions about how we measure overweight and obesity in…
AMA Passes Resolution Calling for Expanded Access to Anti-obesity Medications – Endocrine News
Endocrine Society champions resolution passed by House of Delegates On June 10, the American Medical Association (AMA) House of Delegates today passed the Endocrine Society’s…
AMA Passes Resolution Calling for Expanded Access to Anti-obesity Medications – Endocrine News
Endocrine Society champions resolution passed by House of Delegates On June 10, the American Medical Association (AMA) House of Delegates today passed the Endocrine Society’s…
Pharma Fridays – June 6, 2025 – Endocrine News
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Regeneron Expands Clinical-Stage Obesity Portfolio with Strategic In-Licensing of Novel Dual…
Endocrine Society Endorses Treat and Reduce Obesity Act – Endocrine News
The Endocrine Society today endorsed the introduction of the bipartisan Treat and Reduce Obesity Act (TROA) in the Senate. The legislation will ensure that Medicare…